Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604133 · ClinicalTrials.gov registry record

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry

A clinical trial of Arrhythmia, sponsored by QuesGen Systems.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT03604133 is a study of Arrhythmia that is actively recruiting participants, run by QuesGen Systems. The registered enrollment target is 500 participants, below the 1,857-participant average among 16 other Arrhythmia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604133, a study of Arrhythmia, is actively recruiting participants, sponsored by QuesGen Systems.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.

Conditions Studied

Study Locations (1)

Utah

  • Cardio Surgical Partners, LLC - Lehi

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-08-24
Est. Completion 2028-08-24

Sponsor

QuesGen Systems

2 total trials

What the Registry Record Tells You About NCT03604133

The ClinicalTrials.gov registry entry for NCT03604133 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,857-participant average among 16 other Arrhythmia trials with a reported enrollment target (73% lower). The listed sponsor is QuesGen Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arrhythmia appearing as the primary indexed condition, and to 0 interventions.

NCT03604133 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT03604133 about?

NCT03604133 is a clinical study titled "Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry". The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data c...

What is the current status of trial NCT03604133?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-08-24. Estimated completion is 2028-08-24.

What conditions does trial NCT03604133 study?

This clinical trial studies the following conditions: Arrhythmia.

Who is sponsoring clinical trial NCT03604133?

This trial is sponsored by QuesGen Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03604133 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.